|
DNLZ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.824900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.279900E-02 |
| Normal-vs-Stage2 |
7.807500E-02 |
| Normal-vs-Stage3 |
1.595900E-02 |
| Normal-vs-Stage4 |
8.999700E-02 |
| Stage1-vs-Stage2 |
5.448000E-01 |
| Stage1-vs-Stage3 |
3.558600E-01 |
| Stage1-vs-Stage4 |
8.563200E-01 |
| Stage2-vs-Stage3 |
9.919200E-01 |
| Stage2-vs-Stage4 |
5.115600E-01 |
| Stage3-vs-Stage4 |
3.577200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.993790E-02 |
| Normal-vs-AfricanAmerican |
3.382800E-01 |
| Normal-vs-Asian |
6.481900E-02 |
| Caucasian-vs-AfricanAmerican |
6.262800E-01 |
| Caucasian-vs-Asian |
8.182200E-01 |
| AfricanAmerican-vs-Asian |
5.413400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.830200E-02 |
| Normal-vs-Female |
1.127830E-02 |
| Male-vs-Female |
8.055800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.650300E-02 |
| Normal-vs-Age(41-60Yrs) |
8.921300E-03 |
| Normal-vs-Age(61-80Yrs) |
7.428400E-02 |
| Normal-vs-Age(81-100Yrs) |
8.488200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.264800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.829800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.590600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.857600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.947600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.371000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.227200E-01 |
| Classical-VS-Follicular |
1.224240E-01 |
| Classical-VS-Other |
6.176400E-01 |
| Classical-VS-Normal |
6.422100E-02 |
| Tall-VS-Follicular |
9.731400E-01 |
| Tall-VS-Other |
9.954400E-01 |
| Tall-VS-Normal |
1.340230E-01 |
| Follicular-VS-Other |
9.599400E-01 |
| Follicular-VS-Normal |
5.459700E-03 |
| Other-VS-Normal |
1.393200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.083600E-03 |
| Normal-vs-N1 |
5.667700E-02 |
| N0-vs-N1 |
7.521400E-01 |
|
|
